Join to View Full Profile
1275 York AveNew York, NY 10065
Dr. Ge is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jennifer Ge is an Internal Medicine specialist with subspecialties in Hematology and Oncology, based in New York, NY. She completed her residency in Internal Medicine at Brigham and Women's Hospital and earned her MD/PhD from Harvard Medical School. Currently, she is pursuing a fellowship in Hematology and Medical Oncology at Memorial Sloan Kettering Cancer Center. Her academic background includes a ScB in Applied Mathematics - Biology from Brown University, where she graduated Magna cum laude with Honors. Dr. Ge has contributed significantly to the scientific community with multiple publications, including notable works on triple-negative breast cancer. Her research efforts have been recognized through citations and honors, such as fellowships from Harvard Medical School and a prize from Brown University.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2024 - 2027
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2021 - 2024
Harvard Medical SchoolClass of 2021, MD/PhD
Brown UniversityScB, Applied Mathematics - Biology, Magna cum laude, Honors, 2009 - 2013
Certifications & Licensure
NY State Medical License 2024 - 2026
MA State Medical License 2021 - 2024
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- SF (MNT) Fellowship Harvard Medical School, 2019-2021
- Dana-Farber Cancer Institute MD-PhD Fellowship Harvard Medical School, 2019-2021
- James F. Kidwell Prize in Genetics and Population Biology Brown University, 2013
Publications & Presentations
PubMed
- 7 citationsHeterogeneity and transcriptional drivers of triple-negative breast cancer.Bojana Jovanović, Daniel Temko, Laura E Stevens, Marco Seehawer, Anne Fassl
Cell Reports. 2023-12-26 - 5 citationsProlonged Survival in Patients with Metastatic HER2-Positive Inflammatory Breast Cancer: A Case Report and Review of the Literature.Jennifer Y Ge, Beth Overmoyer
Case Reports in Oncology. 2021-07-06 - 14 citationsDeveloping a pulse oximetry home monitoring protocol for patients suspected with COVID-19 after emergency department discharge.David B. Gootenberg, Nicholas Kurtzman, Thomas A O'Mara, Jennifer Y Ge, David Chiu
BMJ Health & Care Informatics. 2021-07-01
Grant Support
- F30 Ruth L. Kirschstein National Research Service AwardNIH/NCI2018–2021
- Beckman Scholars ProgramBeckman Foundation2012–2013
Research History
- Graduate StudentDana-Farber Cancer Institute, Department of Medical Oncology, Department of Data Sciences. Advisors: Kornelia Polyak, MD, PhD & Franziska Michor, PhD. Dissertation: Tumor evolution and resistance in response to BET inhibitor combination therapies in triple-negative breast cancer2015 - 2019
- Undergraduate Research AssistantBrown University, Department of Ecology & Evolutionary Biology. Advisor: David Rand, PhD. Senior thesis: How do mitochondrial genomes influence transcriptional response to hypoxia in D. melanogaster?2011 - 2013
- Undergraduate Research AssistantBrigham and Women's Hospital, Division of Genetics, Department of Medicine. Advisor: Martha Bulyk, PhD. HST-i2b2 Summer Institute in Bioinformatics and Integrative Genomics (BIG). Effect of CpG methylation on binding affinity of transcription factors2011 - 2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
